5 results
Our proposed randomized controlled trial is the first making this head-to-head comparison in a *real life* primary care setting in the Netherlands. The primary research question is: does a 12-week combination therapy of open label varenicline and…
With this study we compare the BHR and a conventional THP in a young and active patient group, to confirm that for this specific patient group and under favorable implantation circumstances, the BHR is a better solution regarding the post-op…
Primary objective To investigate the safety and tolerability of CCS1477 as monotherapy and in combination.
To compare progression free survival (PFS) between treatment with docetaxel or cabazitaxel and darolutamide versus treatment with docetaxel or cabazitaxel in mCRPC patients.
To determine the influence of darolutamide on the pharmacokinetics of cabazitaxel compared to cabazitaxel alone in mCRPC patients.